Loading…
Human vascular endothelial cells process and present autoantigen to human T cell lines
The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine recept...
Saved in:
Published in: | International immunology 1995-03, Vol.7 (3), p.471-479 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3 |
---|---|
cites | |
container_end_page | 479 |
container_issue | 3 |
container_start_page | 471 |
container_title | International immunology |
container_volume | 7 |
creator | Savage, Caroline O. S. Brooks, Christopher J. Harcourt, Gillian C. Picard, Jean K. King, William Sansom, David M. Willcox, Nicholas |
description | The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells. |
doi_str_mv | 10.1093/intimm/7.3.471 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77350184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14544586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</originalsourceid><addsrcrecordid>eNqFkUFP3DAQha0KRLe0V25IFofestixnbGPBZVuJRBIBYp6sbz2pIQmzhInCP59DbviwIXTWHrfvHnWI2SPszlnRhw2cWy67hDmYi6BfyAzLitWlAJgi8yYUaLQHPRH8imlO8aYKI3YITugJNOVmJHrxdS5SB9c8lPrBoox9OMtto1rqce2TXQ19B5Toi6G_MaEcaRuGnuXD__FSMee3r54XL4s0LaJmD6T7dq1Cb9s5i65Ovl-ebwoTs9__Dz-dlp4afhYLCsEUTmny-C19mhQaQkYFHCtpKyD5HUtwDC3lNoHhWBkpbwORsoylF7skq9r35zyfsI02q5JzzFcxH5KFkAoxrV8FyyZMmVZwbsgr0AbMCKDB2_Au34aYv6t5UaaHFSbDM3XkB_6lAas7WpoOjc8Wc7sc3923Z8FK2zuLy_sb1ynZYfhFd8UlvVirTdpxMdX2Q3_bA4Pyi5u_tgjDme_1O8LeyP-A33Dpn0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194994689</pqid></control><display><type>article</type><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</creator><creatorcontrib>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</creatorcontrib><description>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/7.3.471</identifier><identifier>PMID: 7540863</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Accessory cells ; Amino acids ; Antigen presentation ; Antigen Presentation - drug effects ; Antigens, CD - immunology ; Autoantigens - immunology ; B7-1 Antigen - physiology ; Blood ; CD28 antigen ; CD28 Antigens - immunology ; CD58 antigen ; CD58 Antigens ; Cell activation ; Cell Adhesion Molecules - physiology ; Cell lines ; Cells, Cultured ; Chloroquine ; Chloroquine - pharmacology ; Endothelial cells ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - immunology ; Epitopes ; Epitopes - immunology ; Histocompatibility antigen HLA ; HLA-DQ Antigens - immunology ; HLA-DR Antigens - immunology ; Humans ; Interferon-gamma - pharmacology ; Lymphocytes ; Lymphocytes T ; Membrane Glycoproteins - immunology ; Myasthenia ; Myasthenia gravis ; Myasthenia Gravis - immunology ; Myasthenia Gravis - pathology ; Neuromuscular junctions ; Peptide Fragments - immunology ; Peptides ; Peripheral blood ; Receptors ; Receptors, Cholinergic - immunology ; Signal Transduction ; Signaling ; T lymphocytes ; T-Lymphocytes - immunology ; Umbilical vein ; Umbilical Veins ; γ-Interferon</subject><ispartof>International immunology, 1995-03, Vol.7 (3), p.471-479</ispartof><rights>Copyright Oxford University Press(England) Mar 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7540863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Savage, Caroline O. S.</creatorcontrib><creatorcontrib>Brooks, Christopher J.</creatorcontrib><creatorcontrib>Harcourt, Gillian C.</creatorcontrib><creatorcontrib>Picard, Jean K.</creatorcontrib><creatorcontrib>King, William</creatorcontrib><creatorcontrib>Sansom, David M.</creatorcontrib><creatorcontrib>Willcox, Nicholas</creatorcontrib><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><title>International immunology</title><addtitle>Int Immunol</addtitle><description>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</description><subject>Accessory cells</subject><subject>Amino acids</subject><subject>Antigen presentation</subject><subject>Antigen Presentation - drug effects</subject><subject>Antigens, CD - immunology</subject><subject>Autoantigens - immunology</subject><subject>B7-1 Antigen - physiology</subject><subject>Blood</subject><subject>CD28 antigen</subject><subject>CD28 Antigens - immunology</subject><subject>CD58 antigen</subject><subject>CD58 Antigens</subject><subject>Cell activation</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Cell lines</subject><subject>Cells, Cultured</subject><subject>Chloroquine</subject><subject>Chloroquine - pharmacology</subject><subject>Endothelial cells</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - immunology</subject><subject>Epitopes</subject><subject>Epitopes - immunology</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-DQ Antigens - immunology</subject><subject>HLA-DR Antigens - immunology</subject><subject>Humans</subject><subject>Interferon-gamma - pharmacology</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Myasthenia</subject><subject>Myasthenia gravis</subject><subject>Myasthenia Gravis - immunology</subject><subject>Myasthenia Gravis - pathology</subject><subject>Neuromuscular junctions</subject><subject>Peptide Fragments - immunology</subject><subject>Peptides</subject><subject>Peripheral blood</subject><subject>Receptors</subject><subject>Receptors, Cholinergic - immunology</subject><subject>Signal Transduction</subject><subject>Signaling</subject><subject>T lymphocytes</subject><subject>T-Lymphocytes - immunology</subject><subject>Umbilical vein</subject><subject>Umbilical Veins</subject><subject>γ-Interferon</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkUFP3DAQha0KRLe0V25IFofestixnbGPBZVuJRBIBYp6sbz2pIQmzhInCP59DbviwIXTWHrfvHnWI2SPszlnRhw2cWy67hDmYi6BfyAzLitWlAJgi8yYUaLQHPRH8imlO8aYKI3YITugJNOVmJHrxdS5SB9c8lPrBoox9OMtto1rqce2TXQ19B5Toi6G_MaEcaRuGnuXD__FSMee3r54XL4s0LaJmD6T7dq1Cb9s5i65Ovl-ebwoTs9__Dz-dlp4afhYLCsEUTmny-C19mhQaQkYFHCtpKyD5HUtwDC3lNoHhWBkpbwORsoylF7skq9r35zyfsI02q5JzzFcxH5KFkAoxrV8FyyZMmVZwbsgr0AbMCKDB2_Au34aYv6t5UaaHFSbDM3XkB_6lAas7WpoOjc8Wc7sc3923Z8FK2zuLy_sb1ynZYfhFd8UlvVirTdpxMdX2Q3_bA4Pyi5u_tgjDme_1O8LeyP-A33Dpn0</recordid><startdate>19950301</startdate><enddate>19950301</enddate><creator>Savage, Caroline O. S.</creator><creator>Brooks, Christopher J.</creator><creator>Harcourt, Gillian C.</creator><creator>Picard, Jean K.</creator><creator>King, William</creator><creator>Sansom, David M.</creator><creator>Willcox, Nicholas</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19950301</creationdate><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><author>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Accessory cells</topic><topic>Amino acids</topic><topic>Antigen presentation</topic><topic>Antigen Presentation - drug effects</topic><topic>Antigens, CD - immunology</topic><topic>Autoantigens - immunology</topic><topic>B7-1 Antigen - physiology</topic><topic>Blood</topic><topic>CD28 antigen</topic><topic>CD28 Antigens - immunology</topic><topic>CD58 antigen</topic><topic>CD58 Antigens</topic><topic>Cell activation</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Cell lines</topic><topic>Cells, Cultured</topic><topic>Chloroquine</topic><topic>Chloroquine - pharmacology</topic><topic>Endothelial cells</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - immunology</topic><topic>Epitopes</topic><topic>Epitopes - immunology</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-DQ Antigens - immunology</topic><topic>HLA-DR Antigens - immunology</topic><topic>Humans</topic><topic>Interferon-gamma - pharmacology</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Myasthenia</topic><topic>Myasthenia gravis</topic><topic>Myasthenia Gravis - immunology</topic><topic>Myasthenia Gravis - pathology</topic><topic>Neuromuscular junctions</topic><topic>Peptide Fragments - immunology</topic><topic>Peptides</topic><topic>Peripheral blood</topic><topic>Receptors</topic><topic>Receptors, Cholinergic - immunology</topic><topic>Signal Transduction</topic><topic>Signaling</topic><topic>T lymphocytes</topic><topic>T-Lymphocytes - immunology</topic><topic>Umbilical vein</topic><topic>Umbilical Veins</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Savage, Caroline O. S.</creatorcontrib><creatorcontrib>Brooks, Christopher J.</creatorcontrib><creatorcontrib>Harcourt, Gillian C.</creatorcontrib><creatorcontrib>Picard, Jean K.</creatorcontrib><creatorcontrib>King, William</creatorcontrib><creatorcontrib>Sansom, David M.</creatorcontrib><creatorcontrib>Willcox, Nicholas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Savage, Caroline O. S.</au><au>Brooks, Christopher J.</au><au>Harcourt, Gillian C.</au><au>Picard, Jean K.</au><au>King, William</au><au>Sansom, David M.</au><au>Willcox, Nicholas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human vascular endothelial cells process and present autoantigen to human T cell lines</atitle><jtitle>International immunology</jtitle><addtitle>Int Immunol</addtitle><date>1995-03-01</date><risdate>1995</risdate><volume>7</volume><issue>3</issue><spage>471</spage><epage>479</epage><pages>471-479</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>7540863</pmid><doi>10.1093/intimm/7.3.471</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8178 |
ispartof | International immunology, 1995-03, Vol.7 (3), p.471-479 |
issn | 0953-8178 1460-2377 |
language | eng |
recordid | cdi_proquest_miscellaneous_77350184 |
source | Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025 |
subjects | Accessory cells Amino acids Antigen presentation Antigen Presentation - drug effects Antigens, CD - immunology Autoantigens - immunology B7-1 Antigen - physiology Blood CD28 antigen CD28 Antigens - immunology CD58 antigen CD58 Antigens Cell activation Cell Adhesion Molecules - physiology Cell lines Cells, Cultured Chloroquine Chloroquine - pharmacology Endothelial cells Endothelium, Vascular - drug effects Endothelium, Vascular - immunology Epitopes Epitopes - immunology Histocompatibility antigen HLA HLA-DQ Antigens - immunology HLA-DR Antigens - immunology Humans Interferon-gamma - pharmacology Lymphocytes Lymphocytes T Membrane Glycoproteins - immunology Myasthenia Myasthenia gravis Myasthenia Gravis - immunology Myasthenia Gravis - pathology Neuromuscular junctions Peptide Fragments - immunology Peptides Peripheral blood Receptors Receptors, Cholinergic - immunology Signal Transduction Signaling T lymphocytes T-Lymphocytes - immunology Umbilical vein Umbilical Veins γ-Interferon |
title | Human vascular endothelial cells process and present autoantigen to human T cell lines |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T22%3A04%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20vascular%20endothelial%20cells%20process%20and%20present%20autoantigen%20to%20human%20T%20cell%20lines&rft.jtitle=International%20immunology&rft.au=Savage,%20Caroline%20O.%20S.&rft.date=1995-03-01&rft.volume=7&rft.issue=3&rft.spage=471&rft.epage=479&rft.pages=471-479&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/7.3.471&rft_dat=%3Cproquest_cross%3E14544586%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=194994689&rft_id=info:pmid/7540863&rfr_iscdi=true |